Noteworthy, only the migratory capacity of CD63+ fraction appeared significantly promoted (p ≤ 0.05; Figure 5B), while the proportion of migrating CD63– AML cells in presence of TIMP-1 cells was comparable to that migrated with CXCL12-gradient alone. The gene discussed is CXCL12; the disease is acute myeloid leukemia.